.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Doctor Solomon's mix in May 2026 tilted toward Topical at 40.74% share and Tincture & Sublingual at 32.75%, while Concentrates held 26.51% and climbed to rank 12 in Maryland Concentrates. Year over year, Topical fell 33.40% and Tincture & Sublingual declined 23.35%, contrasting with a 5.94% gain in Concentrates; month over month, Topical dropped 7.66% and Tincture & Sublingual slid 7.62%, while Concentrates surged 32.99%. With overall brand sales down 22.77% YoY and average price down 10.43% YoY to $27.29, the data implies a shift in demand toward value-priced Concentrates and away from legacy wellness formats.
The sharp 32.99% MoM rise in Concentrates alongside a rank at 12 in Maryland and simultaneous 7.66% and 7.62% MoM declines in Topical and Tincture & Sublingual indicates momentum is consolidating in inhalable use-cases. Given that 73.49% of the mix still sits in categories with 33.40% and 23.35% YoY declines, the brand’s current positioning is weighted toward contracting segments even as a 5.94% YoY uptick in Concentrates signals a viable growth lane; the pattern implies reallocating assortment and promotion toward Concentrates could reduce exposure to shrinking wellness formats and stabilize share.
Competitive Landscape
Doctor Solomon's ranks #12 in MD Concentrates in May 2026, improving 5 positions year over year from #17 and edging up 2 ranks from #14 three months ago; against this, the brand sits 3 spots below its category peak of #9 reached in October 2024 and trails the #1 position held by District Cannabis, whose sales grew 73.36% year over year, while Grassroots advanced from #7 to #2 as its sales rose 47.54% year over year—both indicating that competitors are converting faster rank gains into share. With Doctor Solomon's only a 5-rank YoY climb versus competitors moving 5 positions or more into the top 2, the trajectory implies incremental recovery rather than a path back to the #9 peak without a step-change in velocity.
Notable Products
CBD/THC 1:1 Restore Transdermal Lotion (100mg CBD, 100mg THC, 1oz) posted the steepest decline in May 2026 at -29.8% MoM while falling to rank 3, whereas the category leader CBD/THC 1:1 Restore Transdermal Lotion (200mg CBD, 200mg THC, 1.8oz) slid -9.6% MoM but held rank 1. Meanwhile, CBD/THC 3:1 Unwind Transdermal Balm (135mg CBD, 45mg THC) rose 17.1% MoM to rank 2, and CBD/THC 1:3 Rescue Transdermal Balm (30mg CBD, 90mg THC) gained 19.2% MoM at rank 4. With four Topical SKUs occupying ranks 1–4 and one SKU declining sharply while two adjacent balms expanded, the mix implies a shift from 1:1 lotions toward ratio-specific balms capturing near-term demand concentration.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
